BlinkLab Valuation

Is BB1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BB1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BB1's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BB1's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BB1?

Key metric: As BB1 barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for BB1. This is calculated by dividing BB1's market cap by their current book value.
What is BB1's PB Ratio?
PB Ratio	4.5x
Book	AU$6.48m
Market Cap	AU$29.25m

BB1 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	633.1x
Enterprise Value/EBITDA	-14.9x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does BB1's PB Ratio compare to its peers?

The above table shows the PB ratio for BB1 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	7.3x
DOC Doctor Care Anywhere Group	4.5x	108.0%	AU$25.3m
ENL Enlitic	6x	122.8%	AU$37.3m
SHG Singular Health Group	16.5x	n/a	AU$23.8m
AYA Artrya	2.4x	n/a	AU$40.8m
BB1 BlinkLab	4.5x	74.1%	AU$29.2m

Price-To-Book vs Peers: BB1 is good value based on its Price-To-Book Ratio (4.5x) compared to the peer average (7.3x).

Price to Book Ratio vs Industry

How does BB1's PB Ratio compare vs other companies in the AU Healthcare Services Industry?

0 Companies	Price / Book	Estimated Growth	Market Cap

No more companies available in this PB range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: BB1 is expensive based on its Price-To-Book Ratio (4.5x) compared to the Global Healthcare Services industry average (2.5x).

Price to Book Ratio vs Fair Ratio

What is BB1's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BB1 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	4.5x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate BB1's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Doctor Care Anywhere Group

AU$25.3m

Provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland.

DOC

AU$0.07

4.5%

45.8%

CardieX

AU$32.4m

Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.

CDX

AU$0.11

-24.1%

n/a

Cogstate

AU$170.8m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

CGS

AU$0.99

4.2%

-35.5%